Mannkind corporation: mnkd 101 milestone shows promise

MannKind is positioned for growth with the clofazimine inhalation suspension advancing to a phase 2/3 s...

February 13, 2023, 7:23 pm

Energy is in a consolidation phase for a setup to the upside, says cerity's jim lebenthal

Jim Lebenthal, Cerity Partners chief equity strategist, joins 'Closing Bell: Overtime' to discuss whether investors should buy or bail on the energy s...

February 13, 2023, 5:19 pm

Aravive to present positive updated data from phase 1b trial of batiraxcept in combination with cabozantinib for treatment of clear cell renal cell carcinoma at the 2023 asco genitourinary (gu) cancer

HOUSTON, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted...

February 13, 2023, 5:00 pm

Aravive to present positive updated data from phase 1b trial of batiraxcept in combination with cabozantinib for treatment of clear cell renal cell carcinoma at the 2023 asco genitourinary (gu) cancer

HOUSTON, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted...

February 13, 2023, 5:00 pm

Aravive to present positive updated data from phase 1b trial of batiraxcept in combination with cabozantinib for treatment of clear cell renal cell carcinoma at the 2023 asco genitourinary (gu) cancer

HOUSTON, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted...

February 13, 2023, 5:00 pm

Chinook's atrasentan: a promising solution for iga nephropathy?

Chinook is a clinical-stage biopharmaceutical firm that is developing precision medicines for kidney diseases, including treatments for rare, chronic,...

February 13, 2023, 3:02 pm

Eur is giving in without resistance. overview for 13.02.2023

By RoboForex.com EURUSD keeps retreating. The current quote is 1.0670. The currency pair dropped to the lows of five months. The reason is the market ...

February 13, 2023, 2:00 pm

Incyte (incy) reports positive long-term data from hs study

Incyte's (INCY) povorcitinib shows sustained and durable efficacy across all treatment arms in the open-label extension period of the ...

February 13, 2023, 1:33 pm

Western magnesium says testing period at commercial pilot plant gives it “greater confidence”

Western Magnesium Corp. (TSX-V:WMG, OTCQB:MLYF) told investors that testing at its commercial pilot plant has given it more confidence as it progresse...

February 13, 2023, 9:18 am

Little on the agenda in europe today

It is a tense start to the new week with the dollar keeping mixed while equities are pinned slightly lower ahea...

February 13, 2023, 5:45 am

Usd jpy technical analysis: bullish for now, seeking a short soon!

USDJPY technical analysis: Looking at the phases of the market cycle using bull and bear channels

Bull channels are price trends with higher ...

February 12, 2023, 11:56 am

Ocular therapeutix™ announces interim 10-month data from the ongoing u.s. phase 1 clinical trial evaluating otx-tki for the treatment of wet amd

All OTX-TKI treated subjects who were rescue-free at the Month 7 interim analysis remained rescue-free, extending the 73% rescue-free rate up to Month...

February 11, 2023, 1:00 pm

Galapagos: crohn's disease trial failure, still maintaining a buy rating

On February 8th, 2023, Galapagos announced disappointing results of their phase 3 DIVERSITY Crohn's dis...

February 11, 2023, 7:07 am

Gilead (gild) kite reports positive data on car t-cell therapy

Gilead (GILD) reports positive long-term results from the phase I/II study on Tecartus (brexucabtagene ...

February 10, 2023, 12:48 pm

Tartisan nickel to commence fourth phase of environmental baseline studies at kenbridge nickel project

Tartisan Nickel Corp. (CSE:TN, OTCQX:TTSRF) said it has completed three phases of environmental baseline studies at its Kenbridge nickel project in...

February 10, 2023, 8:56 am

Gbp/usd is expected to trade within 1.2015-1.2260 – uob

GBP/USD seems to have now moved into a consolidative phase, likely between 1.2015 and 1.2260, suggest UOB Group’s Economist Lee Sue Ann and Markets ...

February 10, 2023, 8:29 am

Enphase energy: 3 takeaways from its fantastic q4 earnings

Enphase Energy's Q4 2022 earnings showcase its dominance in renewable energy and its plans to produce m...

February 10, 2023, 6:30 am

Why shares of aura biosciences jumped this week

The clinical-stage biotech may be ready to release updated phase 3 trial results on its lead therapy....

February 10, 2023, 6:03 am

Gsk cancer drug gets the fda green light

GSK PLC (LSE:GSK, NYSE:GSK) said that the US Food and Drug Administration (FDA) has granted full approval for Jemperli, a drug for the treatment of mi...

February 10, 2023, 2:59 am

Enphase energy witnesses significant unusual options volume

Following a strong earnings report disclosed on Feb. 7, solar technology specialist Enphase Energy (US:...

February 9, 2023, 10:46 pm